47 reports

He has developed one of the largest and most reputable transplant programs in the world.

  • Genomics
  • Prosthesis
  • Transplantation
  • United States
  • Transplant Genomics Inc.

RESEARCHERS REPORTED SYMPTOMATIC CMV DISEASE WITHIN ONE YEAR OF TRANSPLANTATION.

  • Transplantation
  • Japan
  • North America
  • United States
  • Forecast

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## ## ## Takeda Pharmaceutical Co Ltd ## ## ## ## ## ## ## ## Incyte Corp ## ## ## ## ## ## ## ## Bellicum Pharmaceuticals Inc ## ##

  • Monoclonal Antibody
  • Pharmaceutical
  • Transplantation
  • United States
  • World

CLINICAL TRIALS BY PHASE IN G## COUNTRIES STEM CELL TRANSPLANTATION THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* STEM CELL TRANSPLANTATION THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* STEM CELL TRANSPLANTATION THERAPEUTICS, G## COUNTRIES, CLINIC

  • Drug Development
  • General Medicine And Specialty Medicine
  • Transplantation
  • World
  • Product Initiative

CLINICAL TRIALS BY PHASE IN E## COUNTRIES KIDNEY TRANSPLANT REJECTION THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* KIDNEY TRANSPLANT REJECTION THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* KIDNEY TRANSPLANT REJECTION THERAPEUTICS, E## COUNTRIES,

  • Clinical Trial
  • Immunology
  • Monoclonal Antibody
  • Transplantation
  • Novartis AG

CLINICAL TRIALS BY PHASE IN G## COUNTRIES LUNG TRANSPLANT REJECTION THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* LUNG TRANSPLANT REJECTION THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* LUNG TRANSPLANT REJECTION THERAPEUTICS, G## COUNTRIES, CLINIC

  • Clinical Trial
  • Lung Transplant
  • Monoclonal Antibody
  • Transplantation
  • Novartis AG

CLINICAL TRIALS BY PHASE IN E## COUNTRIES LIVER TRANSPLANT REJECTION THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* LIVER TRANSPLANT REJECTION THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* LIVER TRANSPLANT REJECTION THERAPEUTICS, E## COUNTRIES, CLI

  • Clinical Trial
  • Liver Transplant
  • Therapy
  • Transplantation
  • Novartis AG

HEART TRANSPLANT REJECTION THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2017* CLINICAL TRIALS BY END POINT STATUS HEART TRANSPLANT REJECTION THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2017* HEART TRANSPLANT REJECTION THERAPEUTICS CLINICAL TRIA

  • Clinical Trial
  • Heart Transplant
  • Pharmaceutical
  • Transplantation
  • Novartis AG

TRANSPLANTATION; ##(##): ##-##.

  • Transplantation
  • World
  • Market Size
  • AstraZeneca PLC
  • Merck & Co., Inc.

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Takeda Pharmaceutical Company Ltd ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## Neopharm Ltd ## ## ## ## ## ## ## ## Mallinckrodt Plc ## ## ## ## ## ## ## ## Bellicum Pharmaceutic

  • Clinical Trial
  • Drug Development
  • Pharmaceutical
  • Transplantation
  • World

Transplant Research; ##: ## Gijtenbeek JM, et al. (1999).

  • General Medicine And Specialty Medicine
  • Immunotherapy
  • Medical Biotechnology
  • Transplantation
  • Deals & Alliance

Lung transplant replaces an injured or diseased lung with a healthy one.

  • Cell Therapy
  • Healthcare
  • Therapy
  • Transplantation
  • Product Initiative

Musculoskeletal Transplant Foundation - Medical Equipment - Deals and Alliances Profile, GlobalData Table of Contents ## List of Tables ## List of Figures ## Musculoskeletal Transplant Foundation, Medical Equipment, Deals By Year, 2011 to YTD 2017 ## Musculoskeletal

  • General Medicine And Specialty Medicine
  • Medical Device
  • Transplantation
  • United States
  • M&A

One St.

  • Transplantation
  • United States
  • Jude Medical, Inc.
  • Nanostim, Inc.
  • Thoratec Corporation

Yaccarino' s appointment is effective June ##, 2018.

  • Tissue Banking
  • Transplantation
  • United States
  • Company
  • Litigation And Patent

With many similarities and cross-over between the oncology and transplant patient populations, there is ample opportunity to translate learnings from one area to the other.

  • Transplantation
  • United States
  • Company
  • Company Financials
  • CareDx, Inc.

GlobalData Cellect Biotechnology Ltd reported one pharmaceuticals & healthcare deal worth $## million in YTD 2018.

  • Biotechnology
  • Transplantation
  • United States
  • Company
  • Cellect Biotechnology Ltd.

GlobalData Cellect Biotechnology Ltd, reported one medical equipment deal worth $## million in YTD 2018.

  • Medical Equipment
  • Transplantation
  • United States
  • Company
  • Cellect Biotechnology Ltd.

The company' s products include SBT Resolver, Olerup SSP and XM-ONE.

  • Transplantation
  • United States
  • Company
  • Company Financials
  • CareDx, Inc.

## ## ## ## ## ## ## ## Jazz Pharmaceuticals Plc ## ## ## ## ## ## ## ## Takeda Pharmaceutical Co Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## Bristol-Myers Squibb Co ## ## ## ## ## ## ## ## AbbVie Inc ## ## ## ## ##

  • Hospital
  • Lymphoma
  • Transplantation
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Blood Disease
  • Clinical Trial
  • Leukemia
  • Transplantation
  • Novartis AG

The University of Michigan is one of ## centers participating in the EXPAND clinical trial that will test the effectiveness of the OCS™ Heart to recruit, preserve and assess donor hearts that may not meet current standard donor heart acceptance criteria for transplantation to poten

  • Transplantation
  • United States
  • Company
  • Product Initiative
  • TransMedics, Inc.

The prominent features of this report are - ##.

  • Infectious Disease
  • Medical Biotechnology
  • Therapy
  • Transplantation
  • Chimerix, Inc.

Hoffmann-La Roche Ltd ## ## ## ## ## ## Clinical Research and Biosciences India Private Limited (Inactive) ## ## ## ## ## ## ClinAssess GmbH ## ## ## ## ## ## Bavarian Nordic A/ S ## ## ## ## ## ## AstraZeneca Plc ## ## ## ## ## ## APT

  • Clinical Trial
  • Medical Biotechnology
  • Transplantation
  • World
  • Product Initiative

At six months of follow-up there was no transplant-related mortality.

  • Blood Disease
  • Medical Biotechnology
  • Transplantation
  • World
  • Product Initiative

Each unit consists of one share of its common stock and one warrant to purchase its common stock.

  • Pharmaceutical
  • Transplantation
  • Europe
  • Sweden
  • Advinus

Each unit consists of one share of its common stock and one warrant to purchase its common stock.

  • Pharmaceutical
  • Transplantation
  • Europe
  • Sweden
  • Advinus

## ## ## ## Merck & Co Inc ## ## ## ## ## Groupe Francophone des Myelodysplasies ## ## ## ## ## Daiichi Sankyo Co Ltd ## ## ## ## ## CTI BioPharma Corp ## ## ## ## ## Celerion Inc ## ## ## ## ## Bristol-Myers Squibb C

  • Blood Disease
  • Leukemia
  • Therapy
  • Transplantation
  • Celgene Corporation

The within-patient design evaluates two saphenous vein grafts in the same patient: one treated with DuraGraft versus one treated with the Standard of Care (heparin-dosed saline).

  • Transplantation
  • Europe
  • United States
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Cancer
  • Clinical Trial
  • Leukemia
  • Transplantation
  • Novartis AG